Flag of the European Union EU Clinical Trials Register Help

Clinical trials for acne

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    181 result(s) found for: acne. Displaying page 1 of 10.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2006-003491-35 Sponsor Protocol Number: A0661150 Start Date*: 2007-02-09
    Sponsor Name:PFIZER
    Full Title: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND-DOUBLE DUMMY STUDY, TO EVALUATE EFFICACY AND SAFETY OF TREATMENT WITH AZITHROMYCIN, MICROSPHERES, ORAL POWDER FOR SUSPENSION, 2 G, IN ONE ADMINIST...
    Medical condition: Treatment of moderate-severe inflammatory acne
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000496 Acne LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-024214-54 Sponsor Protocol Number: RD.03.SPR.40129 Start Date*: 2011-04-28
    Sponsor Name:GALDERMA R&D SNC
    Full Title: Exploratory study to assess facial tolerability after daily application of several concentrations and formulations containing CD5789 in acne subjects
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    13.1 10040785 - Skin and subcutaneous tissue disorders 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2016-002492-95 Sponsor Protocol Number: CCJM112X2203 Start Date*: 2017-01-30
    Sponsor Name:Novartis Pharma AG
    Full Title: A randomized, subject and investigator blinded, placebo controlled, multi-center study in parallel groups to assess the efficacy and safety of CJM112 in patients with moderate to severe inflammator...
    Medical condition: Moderate to Severe Inflammatory Acne
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022211-19 Sponsor Protocol Number: RD.03.SPR.40126 Start Date*: 2011-01-07
    Sponsor Name:GALDERMA R&D
    Full Title: PILOT STUDY TO EXPLORE EFFICACY AND SAFETY OF DIFFERENT DOSE REGIMENS OF CD5789 IN SUBJECTS WITH ACNE VULGARIS
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed) HU (Completed)
    Trial results: Removed from public view
    EudraCT Number: 2009-018024-15 Sponsor Protocol Number: CUV100 Start Date*: 2010-05-27
    Sponsor Name:Clinuvel Pharmaceuticals Limited
    Full Title: A Phase II, Randomised, Open Label Pilot Study to Evaluate the Efficacy and Safety of Two Dosage Regimens of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Mild to Moderate Acne...
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-004339-23 Sponsor Protocol Number: 63393/H Start Date*: 2006-01-26
    Sponsor Name:Gedeon Richter Co.
    Full Title: Cink-hyaluronát (Curiosin®) gél és adapalen (Differin®) gél kezelés hatása az életminőség alakulására és a két gyógyszerkészítmény összehasonlító tolerabilitási vizsgálata acnes betegeken.
    Medical condition: Acne Leeds 1B-1C-1D-1E-1F
    Disease: Version SOC Term Classification Code Term Level
    8.0 10000496 PT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2007-000418-35 Sponsor Protocol Number: TT-AVUGANE-Acne-02 Start Date*: 2007-05-22
    Sponsor Name:TopoTarget A/S
    Full Title: A double-blind, randomised, parallel group, placebo-controlled dose finding Phase II study to compare the efficacy and safety of topically applied Avugane™ of different concentrations in subjects w...
    Medical condition: Acne vulgaris of mild to moderate intensity
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-001755-23 Sponsor Protocol Number: RD.06.SPR.18250 Start Date*: 2014-11-25
    Sponsor Name:Galderma R&D SNC
    Full Title: A LONG-TERM SAFETY AND EFFICACY STUDY OF CD5789 50μg/g CREAM IN SUBJECTS WITH ACNE VULGARIS
    Medical condition: Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2013-001753-26 Sponsor Protocol Number: DC0984LE401 Start Date*: 2013-07-25
    Sponsor Name:Pierre Fabre Dermo-cosmétique
    Full Title: Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne.
    Medical condition: Acne
    Disease: Version SOC Term Classification Code Term Level
    18.0 10040785 - Skin and subcutaneous tissue disorders 10000497 Acnes HLT
    18.0 10040785 - Skin and subcutaneous tissue disorders 10000496 Acne PT
    18.0 10040785 - Skin and subcutaneous tissue disorders 10040785 Skin and subcutaneous tissue disorders SOC
    18.0 10040785 - Skin and subcutaneous tissue disorders 10040798 Skin appendage conditions HLGT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2012-004965-41 Sponsor Protocol Number: DS107E-03 Start Date*: 2013-05-16
    Sponsor Name:Dignity Sciences Limited
    Full Title: A Randomised, Double-blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Topically Applied DGLA Cream in Patients with Mild to Moderate Acne Vulgaris
    Medical condition: Patients with mild to moderate facial papulopustular acne (acne comedonica or acne papulopustulosa) will be enrolled in the study.
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed) HU (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2016-000063-16 Sponsor Protocol Number: RD.03.SPR.109807 Start Date*: 2016-06-10
    Sponsor Name:Galderma R&D SNC
    Full Title: Efficacy and safety of CD5024 1% in acne vulgaris
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-002540-13 Sponsor Protocol Number: RD.06.SPR.18252 Start Date*: 2016-01-13
    Sponsor Name:Galderma R&D SNC
    Full Title: A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris
    Medical condition: Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10000519 Acne vulgaris LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) ES (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2014-001491-62 Sponsor Protocol Number: NAICT-001 Start Date*: 2014-08-11
    Sponsor Name:NAICONS Srl.
    Full Title: Clinical efficacy and safety of NAI-Acne gel 3% applied twice-a-day to patients with facial acne vulgaris
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    17.1 10040785 - Skin and subcutaneous tissue disorders 10000496 Acne PT
    Population Age: Adults Gender: Male
    Trial protocol: SK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002842-37 Sponsor Protocol Number: FG-56-02 Start Date*: 2004-11-23
    Sponsor Name:Fujisawa GmbH
    Full Title: A randomised, double-blind, vehicle-controlled, parallel group, multicentre, proof of concept, phase II clinical study to investigate the efficacy and safety of 1 % FR260500 gel in patients with fa...
    Medical condition: Mild to moderate facial acne vulgaris.
    Disease: Version SOC Term Classification Code Term Level
    7.0 10000519 LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2017-003191-30 Sponsor Protocol Number: CLYS006X2201 Start Date*: 2018-07-26
    Sponsor Name:Novartis Pharma AG
    Full Title: A randomized, subject and investigator blinded, placebo-controlled, multi-center study in parallel groups to assess the efficacy and safety of LYS006 in patients with moderate to severe inflammator...
    Medical condition: Inflammatory Acne
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000496 Acne PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed) DE (Completed) HU (Completed) CZ (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2005-004708-35 Sponsor Protocol Number: S194-SP-05 Start Date*: 2007-07-06
    Sponsor Name:Laboratorios Stiefel (España), S.A.
    Full Title: A Multi-Centre, Comparative, Randomized, Single-Blind, Parallel Group, Clinical Trial in Phase IV for the Evaluation of the Subjects Quality of Life, the Efficacy and the Tolerance of Duac® Gel (a ...
    Medical condition: Treatment of acne vulgaris from mild to moderate severity.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: PT (Not Authorised)
    Trial results: (No results available)
    EudraCT Number: 2014-004612-10 Sponsor Protocol Number: BAY86-5300/91772 Start Date*: 2015-01-12
    Sponsor Name:Bayer HealthCare AG
    Full Title: A multicenter, double-blind, randomized, placebo controlled study to evaluate the efficacy and safety of an oral contraceptive preparation YAZ (drospirenone 3 mg / ethinylestradiol 20 µg) for 6 tre...
    Medical condition: Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2014-005235-13 Sponsor Protocol Number: PDTofAcne24.11.2014.version1 Start Date*: 2015-02-10
    Sponsor Name:Sahlgrenska University hospital of gothenburg Department of dermatology
    Full Title: Therapy-treatment (PDT) on Acne, a study to optimize the number of treatments, the right light-dose and the right pre-treatment in order to obtain a longterm remission-time
    Medical condition: Acne
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004858 10000497 Acnes HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-018313-29 Sponsor Protocol Number: PPA/904A/001 Start Date*: 2010-03-23
    Sponsor Name:Photopharmica
    Full Title: Open-label, within-subject controlled, Phase IIa study to investigate repeat dose antimicrobial photodynamic therapy in patients with acne vulgaris.
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000519 Acne Vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2023-000463-32 Sponsor Protocol Number: CB-03-01/25 Start Date*: 2023-04-19
    Sponsor Name:CASSIOPEA SpA
    Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in...
    Medical condition: Facial Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 01 06:38:55 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA